{
    "Variants Include": [
        {
            "Gene": "SNCA",
            "variants": [
                {
                    "HGVS": "NM_000345.2:c.157G>A",
                    "cDNA Change": {
                        "transcript": "NM_000345.2",
                        "ref": "G",
                        "alt": "A",
                        "position": "157"
                    },
                    "Protein Change": {
                        "ref": "Ala",
                        "alt": "Thr",
                        "position": "53"
                    },
                    "Description in input context": "c.157G>A (p.Ala53Thr)"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Parkinson Disease",
        "MONDO": "MONDO:0005149"
    },
    "Experiment Method": [
        {
            "Assay Method": "Establishment of Lymphoblastoid Cell Lines",
            "Material used": {
                "Material Source": "Patients Derived Material",
                "Material Name": "Peripheral blood lymphocytes of a patient with early - onset PD and normal individuals (controls)",
                "Description": "A female patient with early - onset PD was the donor of blood samples. Controls were normal individuals, all of matching age and gender with the patient. Mononuclear cells were obtained from peripheral blood by density gradient centrifugation over Ficoll - Paque PLUS. Transformation was carried out with the use of supernatant obtained from B95 - 8 lymphoblastoid cell line established from peripheral blood lymphocytes of a cotton - top marmoset following in vitro infection with EBV."
            },
            "Readout type": "N.D.",
            "Readout description": [
                {
                    "Variant": "NM_000345.2:c.157G>A",
                    "Conclusion": "N.D.",
                    "Molecular Effect": "N.D.",
                    "Result Description": "N.D."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "N.D.",
                "Description": "N.D."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "N.D."
            }
        },
        {
            "Assay Method": "Cell Lines and Culture Conditions",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "Lymphoblastoid cell lines",
                "Description": "For resuscitation, cells were placed at 37°C for 30 sec, transferred to 10 ml of cold culture medium while in ice, collected by a 5 min spin at 1,000 rpm and resuspended in 5 - ml fresh RPMI. Cells were maintained in RPMI 1640, supplemented with L - glutamine (2 mM), penicillin (100 U/ml), streptomycin (100 U/ml), sodium pyruvate (1 mM), sodium bicarbonate (50 mM), non - essential amino acids (1×) and 10% heat - inactivated fetal bovine serum (FBS), at 37°C in a humidified 5% CO₂ atmosphere."
            },
            "Readout type": "N.D.",
            "Readout description": [
                {
                    "Variant": "NM_000345.2:c.157G>A",
                    "Conclusion": "N.D.",
                    "Molecular Effect": "N.D.",
                    "Result Description": "N.D."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "N.D.",
                "Description": "N.D."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "N.D."
            }
        },
        {
            "Assay Method": "Detection of the c.157G>A (Formerly G209A) Sequence Variation",
            "Material used": {
                "Material Source": "Patients Derived Material/Cell line",
                "Material Name": "Blood and lymphoblastoid cell lines from the patient and controls",
                "Description": "Blood samples were collected after informed consent. DNA from blood and from lymphoblastoid cell lines was extracted. RNA from lymphoblastoid cell lines was also extracted."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.2:c.157G>A",
                    "Conclusion": "The patient was found to carry the p.Ala53Thr mutation, and monoallelic expression of the normal SNCA allele was documented as the band pattern expected for the mutant allele was absent in RT - PCR analysis",
                    "Molecular Effect": "N.D.",
                    "Result Description": "PCR product was 216 bp. Mutation c.157G>A creates a polymorphic site for enzyme Tsp45I, and the mutant allele is identified by RFLP analysis. RT - PCR product is 500 bp, and the mutant allele is identified by RFLP analysis after Tsp45I digestion. Digestion of the wild - type allele of the SNCA gene with this enzyme gives four fragments (249, 218, 24, and 9 bp), whereas digestion of the c.157G>A allele gives five fragments (249, 185, 33, 24, and 9 bp). Bands from 33 bp down to 9 bp are not detectable with the present system."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "N.D.",
                "Description": "N.D."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "DNA and Chromatin Modification Assays",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "Lymphoblastoid cell lines from the patient",
                "Description": "Cells were used at a concentration of 2.5 - 3×10⁵ cells/ml in a total volume of 10 ml per flask, and subsequently, a drug (5 - aza - 2 - deoxycytidine, 4 - phenylbutyrate or trichostatin A) was added to a flask and was thoroughly resuspended. In all cases a control flask was left untreated."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.2:c.157G>A",
                    "Conclusion": "5 - aza - 2 - deoxycytidine did not reactivate the silenced allele, while 4 - phenylbutyrate and trichostatin A reactivated the silenced allele",
                    "Molecular Effect": "N.D.",
                    "Result Description": "Treatment with 5 - aza - 2 - deoxycytidine (1.0 mM daily dose for 48 hr) showed no reactivation of the silenced allele. Treatment with 4 - phenylbutyrate (5 mM for 24 hr) and trichostatin A (0.5 mM for maximum 15 hr) reactivated the silenced allele."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "A control flask was left untreated."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "CpG Analysis for DNA Methylation",
            "Material used": {
                "Material Source": "Patients Derived Material/Control",
                "Material Name": "DNA from the patient and three unrelated, normal control individuals",
                "Description": "Two micrograms of DNA diluted in 20 ml ddH₂O were denatured, treated with hydroquinone/sodium bisulphite solution, and then processed through several steps including purification, incubation with NaOH, and further purification. PCR reactions were performed using five different primer sets on bisulphite - modified DNA."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.2:c.157G>A",
                    "Conclusion": "All analyzed CpG sites were found to be unmethylated in the patient and in normal controls",
                    "Molecular Effect": "N.D.",
                    "Result Description": "PCR products were electrophoresed in a 2% agarose gel to confirm size and identity. For primer set No1 PCR products were digested by the single - cutting methylation - sensitive enzyme AciI. All PCR products were purified and sequenced."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "N.D.",
                "Description": "N.D."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Real - Time PCR",
            "Material used": {
                "Material Source": "Patients Derived Material/Control",
                "Material Name": "RNA from blood of the patient and normal controls",
                "Description": "RNA was extracted from blood with RNeasy s Mini Kit. RNA was reverse transcribed to cDNA. For real - time PCR, dilutions 1/10 and 1/100 cDNA were amplified using QuantyiFast SYBER Green PCR and the LightCycler2.0."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.2:c.157G>A",
                    "Conclusion": "The mRNA in the control ranged from 65.1% to 86.2% of the mRNA of the patient in one set of experiments, and an average of two - fold increase in total SNCA mRNA in the patient was found compared with the total SNCA mRNA of four different control individuals in multiple experiments",
                    "Molecular Effect": "N.D.",
                    "Result Description": "The target SNCA cDNA primers were used, and for data normalization, the Synaptophysin (SYP) gene was used as internal control."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Three different experiments with each of the four control individuals were carried out."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "N.D.",
                "Description": "N.D."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Copy Number Variation (CNV) Analysis",
            "Material used": {
                "Material Source": "Patients Derived Material",
                "Material Name": "Genomic DNA of the patient",
                "Description": "Whole genome analysis was performed by microarray analysis using Affymetrix GeneChip Mapping 250 K arrays. 250 ng of total genomic DNA were digested with NspI, ligated with adaptors, amplified, fragmented, labeled